Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05307770 · ClinicalTrials.gov registry record · NA
Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05307770: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT05307770 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05307770, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this research is to compare the efficacy of immediate versus extended-release melatonin as a supplement affecting the sleep cycle in patients with Parkinson disease and Rapid Eye Movement Sleep Behavior Disorder.
Interventions
- DIETARY_SUPPLEMENT Immediate Release Melatonin
- DIETARY_SUPPLEMENT Extended Release Melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05307770
The ClinicalTrials.gov registry entry for NCT05307770 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Immediate Release Melatonin is the first listed.
NCT05307770 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05307770 about?
NCT05307770 is a clinical study titled "Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder". The purpose of this research is to compare the efficacy of immediate versus extended-release melatonin as a supplement affecting the sleep cycle in patients with Parkinson disease and Rapid Eye Movement Sleep Behavior Disorder.
What is the current status of trial NCT05307770?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2022-05-01. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT05307770?
The interventions under investigation include: Immediate Release Melatonin (DIETARY_SUPPLEMENT), Extended Release Melatonin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05307770?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.